Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000062

EVP, Chief Scientific Officer sold 6,978 shares at $38.89 ($271,356)

  • EVP, Chief Scientific Officer acquired 19,417 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-17 Exercise or conversion : show line 1 in the form +19,417 74,833 D
2023-01-18 Sale : show line 2 in the form −6,978 $38.89 $271,356 67,855 D
Open-market sales · 6,978 sh · avg $38.89 · $271,356

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2023-01-17 Exercise or conversion : show line 3 in the form Restricted Stock Unit −19,417 $0.00 19,417 21,414 D
Loading xslF345X03/edgardoc.xml…